Table 2.
Overall- and disease-free-survival after the treatment ended.
| n | p value | |
|---|---|---|
| Overall survival | ||
| Osimertinib | 9 | 0.324 |
| Osimertinib + BV | 9 | |
| Disease-free survival | ||
| Osimertinib | 7 | 0.925 |
| Osimertinib + BV | 6 | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.